STEAP4 and steatosis: Hepatic STAMP2 alleviated HFD-induced steatosis through downregulation of lipogenic and adipogenic transcription factors, sterol response element binding protein 1 (SREBP1), and peroxisome proliferator-activated receptor (PPARγ) [25].